SART1: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
 
m (Bot: HTTP→HTTPS)
 
Line 1: Line 1:
{{Infobox_gene}}
'''U4/U6.U5 tri-snRNP-associated protein 1''' is a [[protein]] that in humans is encoded by the ''SART1'' [[gene]].<ref name="pmid9449708">{{cite journal | vauthors = Shichijo S, Nakao M, Imai Y, Takasu H, Kawamoto M, Niiya F, Yang D, Toh Y, Yamana H, Itoh K | title = A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes | journal = J Exp Med | volume = 187 | issue = 3 | pages = 277–88 |date=Mar 1998 | pmid = 9449708 | pmc = 2212124 | doi =10.1084/jem.187.3.277  }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: SART1 squamous cell carcinoma antigen recognized by T cells| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=9092| accessdate = }}</ref>
This gene encodes two [[protein]]s, the SART1(800) protein expressed in the nucleus of the majority of [[cell growth|proliferating cells]], and the SART1(259) protein expressed in the cytosol of [[carcinoma|epithelial cancers]]. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection [[antigen]]s. The SART1(259) protein possesses tumor [[epitope]]s capable of inducing [[HLA-A24]]02-restricted cytotoxic [[T lymphocyte]]s in cancer patients. This SART1(259) antigen may be useful in specific [[immunotherapy]] for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with [[atopy]]. The SART1(259) protein is found to be essential for the recruitment of the tri-[[snRNP]] to the pre-[[spliceosome]] in the spliceosome assembly pathway.<ref name="entrez"/>
==References==
{{Reflist}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal  | vauthors=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8  }}
*{{cite journal  | vauthors=Bonaldo MF, Lennon G, Soares MB |title=Normalization and subtraction: two approaches to facilitate gene discovery. |journal=Genome Res. |volume=6 |issue= 9 |pages= 791–806 |year= 1997 |pmid= 8889548 |doi=10.1101/gr.6.9.791  }}
*{{cite journal  |vauthors=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, etal |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=10.1016/S0378-1119(97)00411-3  }}
*{{cite journal  |vauthors=Valenta R, Natter S, Seiberler S, etal |title=Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. |journal=J. Invest. Dermatol. |volume=111 |issue= 6 |pages= 1178–83 |year= 1999 |pmid= 9856836 |doi= 10.1046/j.1523-1747.1998.00413.x }}
*{{cite journal  |vauthors=Kikuchi M, Nakao M, Inoue Y, etal |title=Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes. |journal=Int. J. Cancer |volume=81 |issue= 3 |pages= 459–66 |year= 1999 |pmid= 10209962 |doi=10.1002/(SICI)1097-0215(19990505)81:3<459::AID-IJC21>3.0.CO;2-6  }}
*{{cite journal  |vauthors=Matsunaga K, Nakao M, Masuoka K, etal |title=Cytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptide. |journal=Jpn. J. Cancer Res. |volume=90 |issue= 9 |pages= 1007–15 |year= 1999 |pmid= 10551332 |doi=  10.1111/j.1349-7006.1999.tb00849.x}}
*{{cite journal  |vauthors=Ishida H, Komiya S, Inoue Y, etal |title=Expression of the SART1 tumor-rejection antigen in human osteosarcomas. |journal=Int. J. Oncol. |volume=17 |issue= 1 |pages= 29–32 |year= 2000 |pmid= 10853014 |doi=  10.3892/ijo.17.1.29}}
*{{cite journal  |vauthors=Shintaku I, Kawagoe N, Yutani S, etal |title=Expression of the SART1 tumor rejection antigen in renal cell carcinoma. |journal=Urol. Res. |volume=28 |issue= 3 |pages= 178–84 |year= 2000 |pmid= 10929426 |doi=10.1007/s002400000103  }}
*{{cite journal  |vauthors=Tanaka S, Tsuda N, Kawano K, etal |title=Expression of tumor-rejection antigens in gynecologic cancers. |journal=Jpn. J. Cancer Res. |volume=91 |issue= 11 |pages= 1177–84 |year= 2001 |pmid= 11092984 |doi=  10.1111/j.1349-7006.2000.tb00902.x}}
*{{cite journal  |vauthors=Sasatomi T, Yamana H, Shichijo S, etal |title=Expression of the SART1 tumor-rejection antigens in colorectal cancers. |journal=Dis. Colon Rectum |volume=43 |issue= 12 |pages= 1754–8 |year= 2001 |pmid= 11156463 |doi=10.1007/BF02236863  }}
*{{cite journal  | vauthors=Makarova OV, Makarov EM, Lührmann R |title=The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes. |journal=EMBO J. |volume=20 |issue= 10 |pages= 2553–63 |year= 2001 |pmid= 11350945 |doi= 10.1093/emboj/20.10.2553  | pmc=125249 }}
*{{cite journal  | vauthors=Bolland DJ, Hewitt JE |title=Intron loss in the SART1 genes of Fugu rubripes and Tetraodon nigroviridis. |journal=Gene |volume=271 |issue= 1 |pages= 43–9 |year= 2001 |pmid= 11410364 |doi=10.1016/S0378-1119(01)00504-2  }}
*{{cite journal  |vauthors=Jurica MS, Licklider LJ, Gygi SR, etal |title=Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. |journal=RNA |volume=8 |issue= 4 |pages= 426–39 |year= 2002 |pmid= 11991638 |doi=10.1017/S1355838202021088  | pmc=1370266  }}
*{{cite journal  |vauthors=Bell M, Schreiner S, Damianov A, etal |title=p110, a novel human U6 snRNP protein and U4/U6 snRNP recycling factor. |journal=EMBO J. |volume=21 |issue= 11 |pages= 2724–35 |year= 2002 |pmid= 12032085 |doi= 10.1093/emboj/21.11.2724  | pmc=126028 }}
*{{cite journal  |vauthors=Wheatley AP, Bolland DJ, Hewitt JE, etal |title=Identification of the autoantigen SART-1 as a candidate gene for the development of atopy. |journal=Hum. Mol. Genet. |volume=11 |issue= 18 |pages= 2143–6 |year= 2003 |pmid= 12189166 |doi=10.1093/hmg/11.18.2143  }}
*{{cite journal  |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899  | pmc=139241 }}
*{{cite journal  |vauthors=Ota T, Suzuki Y, Nishikawa T, etal |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }}
*{{cite journal  |vauthors=Vertegaal AC, Ogg SC, Jaffray E, etal |title=A proteomic study of SUMO-2 target proteins. |journal=J. Biol. Chem. |volume=279 |issue= 32 |pages= 33791–8 |year= 2004 |pmid= 15175327 |doi= 10.1074/jbc.M404201200 }}
*{{cite journal  |vauthors=Beausoleil SA, Jedrychowski M, Schwartz D, etal |title=Large-scale characterization of HeLa cell nuclear phosphoproteins. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=101 |issue= 33 |pages= 12130–5 |year= 2004 |pmid= 15302935 |doi= 10.1073/pnas.0404720101  | pmc=514446 }}
}}
{{refend}}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
{{PBB_Controls
| update_page = yes  
| update_page = yes
| require_manual_inspection = no  
| require_manual_inspection = no
| update_protein_box = yes
| update_protein_box = yes
| update_summary = yes
| update_summary = yes
Line 8: Line 41:
}}
}}


<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
[[Category:Spliceosome]]
{{GNF_Protein_box
| image = 
| image_source = 
| PDB =
| Name = Squamous cell carcinoma antigen recognized by T cells
| HGNCid = 10538
| Symbol = SART1
| AltSymbols =; Ara1; HOMS1; MGC2038; SART1259; Snu66
| OMIM = 605941
| ECnumber = 
| Homologene = 38015
| MGIid = 1309453
| GeneAtlas_image1 = PBB_GE_SART1_200052_s_at_tn.png
| Function = {{GNF_GO|id=GO:0003674 |text = molecular_function}}
| Component = {{GNF_GO|id=GO:0005634 |text = nucleus}} {{GNF_GO|id=GO:0005681 |text = spliceosome}} {{GNF_GO|id=GO:0005737 |text = cytoplasm}} {{GNF_GO|id=GO:0005829 |text = cytosol}}
| Process = {{GNF_GO|id=GO:0006397 |text = mRNA processing}} {{GNF_GO|id=GO:0007050 |text = cell cycle arrest}} {{GNF_GO|id=GO:0008380 |text = RNA splicing}} {{GNF_GO|id=GO:0008629 |text = induction of apoptosis by intracellular signals}} {{GNF_GO|id=GO:0045585 |text = positive regulation of cytotoxic T cell differentiation}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 9092
    | Hs_Ensembl = ENSG00000175467
    | Hs_RefseqProtein = NP_005137
    | Hs_RefseqmRNA = NM_005146
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = 11
    | Hs_GenLoc_start = 65485776
    | Hs_GenLoc_end = 65504183
    | Hs_Uniprot = O43290
    | Mm_EntrezGene = 20227
    | Mm_Ensembl = ENSMUSG00000039148
    | Mm_RefseqmRNA = NM_016882
    | Mm_RefseqProtein = NP_058578
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 19
    | Mm_GenLoc_start = 5380060
    | Mm_GenLoc_end = 5388703
    | Mm_Uniprot = Q9Z315
  }}
}}
'''Squamous cell carcinoma antigen recognized by T cells''', also known as '''SART1''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: SART1 squamous cell carcinoma antigen recognized by T cells| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=9092| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title =
| summary_text = This gene encodes two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation; its full-length sequence is not published yet. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway.<ref name="entrez">{{cite web | title = Entrez Gene: SART1 squamous cell carcinoma antigen recognized by T cells| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=9092| accessdate = }}</ref>
}}
==References==
{{reflist|2}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal  | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171-4 |year= 1994 |pmid= 8125298 |doi=  }}
*{{cite journal  | author=Bonaldo MF, Lennon G, Soares MB |title=Normalization and subtraction: two approaches to facilitate gene discovery. |journal=Genome Res. |volume=6 |issue= 9 |pages= 791-806 |year= 1997 |pmid= 8889548 |doi=  }}
*{{cite journal  | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, ''et al.'' |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149-56 |year= 1997 |pmid= 9373149 |doi=  }}
*{{cite journal  | author=Shichijo S, Nakao M, Imai Y, ''et al.'' |title=A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. |journal=J. Exp. Med. |volume=187 |issue= 3 |pages= 277-88 |year= 1998 |pmid= 9449708 |doi=  }}
*{{cite journal  | author=Valenta R, Natter S, Seiberler S, ''et al.'' |title=Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. |journal=J. Invest. Dermatol. |volume=111 |issue= 6 |pages= 1178-83 |year= 1999 |pmid= 9856836 |doi= 10.1046/j.1523-1747.1998.00413.x }}
*{{cite journal  | author=Kikuchi M, Nakao M, Inoue Y, ''et al.'' |title=Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes. |journal=Int. J. Cancer |volume=81 |issue= 3 |pages= 459-66 |year= 1999 |pmid= 10209962 |doi=  }}
*{{cite journal  | author=Matsunaga K, Nakao M, Masuoka K, ''et al.'' |title=Cytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptide. |journal=Jpn. J. Cancer Res. |volume=90 |issue= 9 |pages= 1007-15 |year= 1999 |pmid= 10551332 |doi=  }}
*{{cite journal  | author=Ishida H, Komiya S, Inoue Y, ''et al.'' |title=Expression of the SART1 tumor-rejection antigen in human osteosarcomas. |journal=Int. J. Oncol. |volume=17 |issue= 1 |pages= 29-32 |year= 2000 |pmid= 10853014 |doi=  }}
*{{cite journal  | author=Shintaku I, Kawagoe N, Yutani S, ''et al.'' |title=Expression of the SART1 tumor rejection antigen in renal cell carcinoma. |journal=Urol. Res. |volume=28 |issue= 3 |pages= 178-84 |year= 2000 |pmid= 10929426 |doi=  }}
*{{cite journal  | author=Tanaka S, Tsuda N, Kawano K, ''et al.'' |title=Expression of tumor-rejection antigens in gynecologic cancers. |journal=Jpn. J. Cancer Res. |volume=91 |issue= 11 |pages= 1177-84 |year= 2001 |pmid= 11092984 |doi=  }}
*{{cite journal  | author=Sasatomi T, Yamana H, Shichijo S, ''et al.'' |title=Expression of the SART1 tumor-rejection antigens in colorectal cancers. |journal=Dis. Colon Rectum |volume=43 |issue= 12 |pages= 1754-8 |year= 2001 |pmid= 11156463 |doi=  }}
*{{cite journal  | author=Makarova OV, Makarov EM, Lührmann R |title=The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes. |journal=EMBO J. |volume=20 |issue= 10 |pages= 2553-63 |year= 2001 |pmid= 11350945 |doi= 10.1093/emboj/20.10.2553 }}
*{{cite journal  | author=Bolland DJ, Hewitt JE |title=Intron loss in the SART1 genes of Fugu rubripes and Tetraodon nigroviridis. |journal=Gene |volume=271 |issue= 1 |pages= 43-9 |year= 2001 |pmid= 11410364 |doi=  }}
*{{cite journal  | author=Jurica MS, Licklider LJ, Gygi SR, ''et al.'' |title=Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. |journal=RNA |volume=8 |issue= 4 |pages= 426-39 |year= 2002 |pmid= 11991638 |doi=  }}
*{{cite journal  | author=Bell M, Schreiner S, Damianov A, ''et al.'' |title=p110, a novel human U6 snRNP protein and U4/U6 snRNP recycling factor. |journal=EMBO J. |volume=21 |issue= 11 |pages= 2724-35 |year= 2002 |pmid= 12032085 |doi= 10.1093/emboj/21.11.2724 }}
*{{cite journal  | author=Wheatley AP, Bolland DJ, Hewitt JE, ''et al.'' |title=Identification of the autoantigen SART-1 as a candidate gene for the development of atopy. |journal=Hum. Mol. Genet. |volume=11 |issue= 18 |pages= 2143-6 |year= 2003 |pmid= 12189166 |doi=  }}
*{{cite journal  | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal  | author=Ota T, Suzuki Y, Nishikawa T, ''et al.'' |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40-5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }}
*{{cite journal  | author=Vertegaal AC, Ogg SC, Jaffray E, ''et al.'' |title=A proteomic study of SUMO-2 target proteins. |journal=J. Biol. Chem. |volume=279 |issue= 32 |pages= 33791-8 |year= 2004 |pmid= 15175327 |doi= 10.1074/jbc.M404201200 }}
*{{cite journal  | author=Beausoleil SA, Jedrychowski M, Schwartz D, ''et al.'' |title=Large-scale characterization of HeLa cell nuclear phosphoproteins. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=101 |issue= 33 |pages= 12130-5 |year= 2004 |pmid= 15302935 |doi= 10.1073/pnas.0404720101 }}
}}
{{refend}}


{{protein-stub}}
{{gene-11-stub}}
{{WikiDoc Sources}}

Latest revision as of 05:54, 11 September 2017

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

U4/U6.U5 tri-snRNP-associated protein 1 is a protein that in humans is encoded by the SART1 gene.[1][2] This gene encodes two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway.[2]

References

  1. ↑ Shichijo S, Nakao M, Imai Y, Takasu H, Kawamoto M, Niiya F, Yang D, Toh Y, Yamana H, Itoh K (Mar 1998). "A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes". J Exp Med. 187 (3): 277–88. doi:10.1084/jem.187.3.277. PMC 2212124. PMID 9449708.
  2. ↑ 2.0 2.1 "Entrez Gene: SART1 squamous cell carcinoma antigen recognized by T cells".

Further reading


Retrieved from "https://www.wikidoc.org/index.php?title=SART1&oldid=1414849"